Recent Advances in Magnetic Resonance Imaging Assessment of Renal Fibrosis

Advances in Chronic Kidney Disease

Volumn 24, Issue 3, 2017, Pages 150-153

  Li, Jia ^a   An, Changlong ^a   Kang, Lei ^a   Mitch, William E ^a   Wang, Yanlin ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; Extracellular matrix; Fibroblast; Fibrosis; Magnetic resonance imaging

Indexed keywords

BIOLOGICAL MARKER; GADOLINIUM;

APPARENT DIFFUSION COEFFICIENT; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; ESTIMATED GLOMERULAR FILTRATION RATE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; KIDNEY BIOPSY; KIDNEY FIBROSIS; MAGNETIC RESONANCE ELASTOGRAPHY; NEPHROGENIC SYSTEMIC FIBROSIS; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; DIAGNOSTIC IMAGING; FIBROSIS; KIDNEY; PATHOLOGY;

FIBROSIS; HUMANS; KIDNEY; MAGNETIC RESONANCE IMAGING; RENAL INSUFFICIENCY, CHRONIC;

EID: 85019237622     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2017.03.005     Document Type: Review

References (50)

1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385 (2015), 117–171.
2. Meguid El Nahas, A., Bello, A.K., Chronic kidney disease: the global challenge. Lancet 365 (2005), 331–340.
3. Zeisberg, M., Neilson, E.G., Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21 (2010), 1819–1834.
4. Liu, Y., Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7 (2011), 684–696.
5. Nath, K.A., Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20 (1992), 1–17.
6. Nath, K.A., The tubulointerstitium in progressive renal disease. Kidney Int 54 (1998), 992–994.
7. Strutz, F., Zeisberg, M., Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 17 (2006), 2992–2998.
8. Mack, M., Yanagita, M., Origin of myofibroblasts and cellular events triggering fibrosis. Kidney Int 87 (2015), 297–307.
9. Sakai, N., Wada, T., T helper 2 cytokine signaling in bone marrow-derived fibroblasts: a target for renal fibrosis. J Am Soc Nephrol 26 (2015), 2896–2898.
10. Dong, Y., Yang, M., Zhang, J., et al. Depletion of CD8+ T cells exacerbates CD4+ T cell-induced monocyte-to-fibroblast transition in renal fibrosis. J Immunol 196 (2016), 1874–1881.
11. Yang, J., Lin, S.C., Chen, G., et al. Adiponectin promotes monocyte-to-fibroblast transition in renal fibrosis. J Am Soc Nephrol 24 (2013), 1644–1659.
12. Niedermeier, M., Reich, B., Rodriguez Gomez, M., et al. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci U S A 106 (2009), 17892–17897.
13. Bucala, R., Spiegel, L.A., Chesney, J., et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1 (1994), 71–81.
14. Herzog, E.L., Bucala, R., Fibrocytes in health and disease. Exp Hematol 38 (2010), 548–556.
15. Yan, J., Zhang, Z., Yang, J., et al. JAK3/STAT6 stimulates bone marrow-derived fibroblast activation in renal fibrosis. J Am Soc Nephrol 26 (2015), 3060–3071.
16. Chen, G., Lin, S.C., Chen, J., et al. CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis. J Am Soc Nephrol 22 (2011), 1876–1886.
17. Xia, Y., Jin, X., Yan, J., et al. CXCR6 plays a critical role in angiotensin II-induced renal injury and fibrosis. Arterioscler Thromb Vasc Biol 34 (2014), 1422–1428.
18. Xia, Y., Yan, J., Jin, X., et al. The chemokine receptor CXCR6 contributes to recruitment of bone marrow-derived fibroblast precursors in renal fibrosis. Kidney Int 86 (2014), 327–337.
19. Wynn, T.A., Cellular and molecular mechanisms of fibrosis. J Pathol 214 (2008), 199–210.
20. Kisseleva, T., Brenner, D.A., Mechanisms of fibrogenesis. Exp Biol Med (Maywood) 233 (2008), 109–122.
21. Neilson, E.G., Mechanisms of disease: fibroblasts—a new look at an old problem. Nat Clin Pract Nephrol 2 (2006), 101–108.
22. Eddy, A.A., Progression in chronic kidney disease. Adv Chronic Kidney Dis 12 (2005), 353–365.
23. Iwano, M., Plieth, D., Danoff, T.M., et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110 (2002), 341–350.
24. Sakai, N., Wada, T., Yokoyama, H., et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A 103 (2006), 14098–14103.
25. Grimm, P.C., Nickerson, P., Jeffery, J., et al. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med 345 (2001), 93–97.
26. Broekema, M., Harmsen, M.C., van Luyn, M.J., et al. Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reperfusion in rats. J Am Soc Nephrol 18 (2007), 165–175.
27. Lebleu, V.S., Taduri, G., O'Connell, J., et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19 (2013), 1047–1053.
28. Okamura, D.M., Lopez-Guisa, J.M., Koelsch, K., et al. Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury. Am J Physiol Ren Physiol 293 (2007), F575–F585.
29. Xia, Y., Entman, M.L., Wang, Y., Critical role of CXCL16 in hypertensive kidney injury and fibrosis. Hypertension 62 (2013), 1129–1137.
30. Liang, H., Ma, Z., Peng, H., et al. CXCL16 deficiency attenuates renal injury and fibrosis in salt-sensitive hypertension. Sci Rep, 6, 2016, 28715.
31. Ma, Z., Jin, X., He, L., et al. CXCL16 regulates renal injury and fibrosis in experimental renal artery stenosis. Am J Physiol Heart Circ Physiol 311 (2016), H815–H821.
32. Tapmeier, T.T., Fearn, A., Brown, K., et al. Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. Kidney Int 78 (2010), 351–362.
33. Wynn, T.A., Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 4 (2004), 583–594.
34. Shao, D.D., Suresh, R., Vakil, V., et al. Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol 83 (2008), 1323–1333.
35. Iwashima, Y., Horio, T., Kumada, M., et al. Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol 98 (2006), 1603–1608.
36. Shimotomai, T., Kakei, M., Narita, T., et al. Enhanced urinary adiponectin excretion in IgA-nephropathy patients with proteinuria. Ren Fail 27 (2005), 323–328.
37. Jorsal, A., Tarnow, L., Frystyk, J., et al. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int 74:5 (2008), 649–654.
38. Zoccali, C., Mallamaci, F., Adiponectin and leptin in chronic kidney disease: causal factors or mere risk markers?. J Ren Nutr 21 (2011), 87–91.
39. Mills, K.T., Hamm, L.L., Alper, A.B., et al. Circulating adipocytokines and chronic kidney disease. PLoS One, 8, 2013, e76902.
40. Farris, A.B., Colvin, R.B., Renal interstitial fibrosis: mechanisms and evaluation. Curr Opin Nephrol Hypertens 21 (2012), 289–300.
41. Genovese, F., Manresa, A.A., Leeming, D.J., et al. The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?. Fibrogenesis Tissue Repair, 7, 2014, 4.
42. Wagner, B., Drel, V., Gorin, Y., Pathophysiology of gadolinium-associated systemic fibrosis. Am J Physiol Ren Physiol 311 (2016), F1–F11.
43. Wagner, B., Tan, C., Barnes, J.L., et al. Nephrogenic systemic fibrosis: evidence for oxidative stress and bone marrow-derived fibrocytes in skin, liver, and heart lesions using a 5/6 nephrectomy rodent model. Am J Pathol 181 (2012), 1941–1952.
44. Taylor, D.G., Bushell, M.C., The spatial mapping of translational diffusion coefficients by the NMR imaging technique. Phys Med Biol 30 (1985), 345–349.
45. Inoue, T., Kozawa, E., Okada, H., et al. Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging. J Am Soc Nephrol 22 (2011), 1429–1434.
46. Zhao, J., Wang, Z.J., Liu, M., et al. Assessment of renal fibrosis in chronic kidney disease using diffusion-weighted MRI. Clin Radiol 69 (2014), 1117–1122.
47. Friedli, I., Crowe, L.A., Viallon, M., et al. Improvement of renal diffusion-weighted magnetic resonance imaging with readout-segmented echo-planar imaging at 3T. Magn Reson Imaging 33 (2015), 701–708.
48. Friedli, I., Crowe, L.A., Berchtold, L., et al. New magnetic resonance imaging index for renal fibrosis assessment: a comparison between diffusion-weighted imaging and T1 mapping with histological validation. Sci Rep, 6, 2016, 30088.
49. Venkatesh, S.K., Ehman, R.L., Magnetic resonance elastography of abdomen. Abdom Imaging 40 (2015), 745–759.
50. Lee, C.U., Glockner, J.F., Glaser, K.J., et al. MR elastography in renal transplant patients and correlation with renal allograft biopsy: a feasibility study. Acad Radiol 19 (2012), 834–841.